business

As Miyoba’s placement with FA Bio comes to an end, she reflects on nearly 10 months of learning, growth and hands-on scientific experience that has helped shape both her confidence and future ambitions.

FA Bio has reported encouraging results from its 2025 maize biostimulant field trials, demonstrating consistent positive performance across diverse European growing conditions. The results mark an important step forward in accelerating the company’s lead fungal biostimulant candidates toward commercial development.

At the start of the month, I had the opportunity to attend TechTour Resilient Ag 2026, where founders, investors, corporates and policymakers gathered to discuss one of the most pressing questions facing global food systems, ‘how do we build true resilience into agriculture’?

The UK’s ambition to remain a global leader in science, technology, engineering and mathematics (STEM) depends not only on technical capability, but on people and their ability to contribute fully, challenge ideas and innovate without fear.

Each year, millions of tonnes of nitrogen fertiliser are lost to the environment, contaminating waterways and releasing potent greenhouse gases. With fertiliser prices soaring and soils under strain, the need for nature-based nitrogen solutions has never been more urgent.

At FA Bio, the ability to scale microbial candidates from early-stage research to field-ready solutions is central to discovering products that meet the needs of growers while supporting natural ecosystems. A key part of this journey is our bioreactor.